- Home
- MRNS vs LOCL Comparison
MRNS vs LOCL Comparison
Compare MRNS & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNS
- LOCL
- Stock Information
- Founded
- MRNS 2003
- LOCL 2021
- Country
- MRNS United States
- LOCL United States
- Employees
- MRNS N/A
- LOCL N/A
- Industry
- MRNS Biotechnology: Pharmaceutical Preparations
- LOCL Farming/Seeds/Milling
- Sector
- MRNS Health Care
- LOCL Consumer Staples
- Exchange
- MRNS Nasdaq
- LOCL Nasdaq
- Market Cap
- MRNS 19.0M
- LOCL 21.2M
- IPO Year
- MRNS 2014
- LOCL N/A
- Fundamental
- Price
- MRNS $0.30
- LOCL $2.32
- Analyst Decision
- MRNS Buy
- LOCL
- Analyst Count
- MRNS 12
- LOCL 0
- Target Price
- MRNS $4.28
- LOCL N/A
- AVG Volume (30 Days)
- MRNS 6.6M
- LOCL 4.7K
- Earning Date
- MRNS 11-12-2024
- LOCL 11-14-2024
- Dividend Yield
- MRNS N/A
- LOCL N/A
- EPS Growth
- MRNS N/A
- LOCL N/A
- EPS
- MRNS N/A
- LOCL N/A
- Revenue
- MRNS $31,466,000.00
- LOCL $34,934,000.00
- Revenue This Year
- MRNS $20.74
- LOCL $94.93
- Revenue Next Year
- MRNS $32.38
- LOCL $79.63
- P/E Ratio
- MRNS N/A
- LOCL N/A
- Revenue Growth
- MRNS 1.63
- LOCL 27.83
- 52 Week Low
- MRNS $0.26
- LOCL $1.56
- 52 Week High
- MRNS $11.26
- LOCL $4.60
- Technical
- Relative Strength Index (RSI)
- MRNS 25.07
- LOCL 36.89
- Support Level
- MRNS $0.29
- LOCL $2.30
- Resistance Level
- MRNS $0.37
- LOCL $2.44
- Average True Range (ATR)
- MRNS 0.04
- LOCL 0.15
- MACD
- MRNS 0.02
- LOCL -0.02
- Stochastic Oscillator
- MRNS 17.95
- LOCL 39.53
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
About LOCL Local Bounti Corporation
Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.